NeurAxis, Inc.
AMEX:NRXSBiotechnology
+$0.29 today
- Market cap
- $69.12M
- Beta
- 1.41
- P/E (TTM)
- -10.5
- EPS (TTM)
- -$0.67
Volume 0.23M
Average 0.18M
NRXS Interest Expense
Cost of servicing the company's debt during the period.
NeurAxis, Inc.AMEX: NRXS
Interest Expense · Q1 FY2026 · quarter ended Mar 2026
Interest expense turns negative
Q1 FY2026 interest expense was -$26.19K, compared with $2.24K a year earlier. Trailing-twelve-month interest expense was $45.54K. Over 3 fiscal years it compounded at -43.8% a year.
Context
- Interest expense amounted to 2.1% of revenue in FY2025, down 9.1 pp from a year earlier.
- Interest expense increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly interest expense holds near -$26.19K or moves back toward the trailing-twelve-month quarterly average of $11.39K.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Expense history
USD · from the income statement
- Latest · FY2025
- 73.97K USD
- Year-over-year change
- -75.4%
- 4-year CAGR
- +19.0%
| Period | Period end | Interest Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 73.97K | -75.4% |
| FY2024 | 2024-12-31 | 300.72K | -94.4% |
| FY2023 | 2023-12-31 | 5.36M | +1183.1% |
| FY2022 | 2022-12-31 | 417.6K | +1030.9% |
| FY2021 | 2021-12-31 | 36.93K | — |
Interest Expense vs competitors
How NRXS compares with its peers on the latest reported figures
- NRXS's LTM Mar 2026 interest expense of $45.54K is the highest of the 4 companies compared; the peer median is $0.
- Its year-over-year change of -82.1% is the highest of 2, against a peer median of -100.0%.
- Interest expense amounts to 1.1% of revenue for NRXS, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
NRXSNeurAxis, Inc. | LTM Mar 2026 | $45.54K | -82.1% | -43.8% | 1.1% |
| LTM Jun 2026 | $0 | — | — | — | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Dec 2025 | $0 | -100.0% | -86.5% | — | |
| Peer median (excluding NRXS) | $0 | -100.0% | -86.5% | 0.0% | |
Competitors are the stored peer set for NRXS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.72M | 2.68M | 2.46M | 2.69M | 3.57M |
| Cost of Revenue | 467.66K | 297.06K | 303.35K | 362K | 562.92K |
| Gross Profit | 2.25M | 2.39M | 2.16M | 2.32M | 3.01M |
| Gross Margin | 82.8% | 88.9% | 87.7% | 86.5% | 84.2% |
| Research & Development | 203.41K | 225.61K | 169.32K | 206.11K | 493.61K |
| Selling, General & Admin | 5.02M | 5.53M | 8.65M | 9.27M | 10.34M |
| Operating Expenses | 5.22M | 5.76M | 8.82M | 9.48M | 10.84M |
| Depreciation & Amortization | 36.71K | 37.13K | 40.73K | 37.83K | 59.5K |
| EBITDA | (2.95M) | (4.33M) | (9.23M) | (7.9M) | (7.67M) |
| EBITDA Margin | -108.6% | -161.1% | -375.1% | -294.2% | -214.8% |
| Operating Income | (2.97M) | (3.37M) | (6.66M) | (7.16M) | (7.83M) |
| Operating Margin | -109.1% | -125.6% | -270.9% | -266.5% | -219.4% |
| Interest Income | 0 | (2.32M) | (2.77K) | 0 | 0 |
| Interest Expense | 36.93K | 417.6K | 5.36M | 300.72K | 73.97K |
| Other Income / Expenses | (58K) | (1.41M) | (7.96M) | (1.08M) | 29.35K |
| Income Before Tax | (3.03M) | (4.78M) | (14.63M) | (8.24M) | (7.8M) |
| Pre-Tax Margin | -111.3% | -178.0% | -594.6% | -306.8% | -218.5% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (3.03M) | (4.78M) | (14.63M) | (8.24M) | (7.8M) |
| Net Margin | -111.3% | -178.0% | -594.6% | -306.8% | -218.5% |
| EPS (Basic) | (0.62) | (0.57) | (2.32) | (1.22) | (0.95) |
| EPS (Diluted) | (0.62) | (0.78) | (2.32) | (1.22) | (0.95) |
| Weighted Avg Shares | 5.38M | 8.41M | 6.3M | 6.92M | 9.08M |
| Weighted Avg Shares (Diluted) | 5.38M | 8.41M | 6.3M | 6.92M | 9.08M |
NeurAxis, Inc.
AMEX:NRXS
Intrinsic Alpha fair value
Locked
Current Price
$4.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.